Ruth E. Billings
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
- Sulfur Compounds in Biology
Papers in
- Biochemistry 11
- Eicosanoids and Hypertension Pharmacology 8
- Co-authors
- Gregory M. Adamson (4 shared papers)Robert E. McMahon (11 shared papers)Timothy J. Carlson (3 shared papers)Thomas R. Tephly (4 shared papers)Dawn L. Duval (3 shared papers)David J. Sieg (2 shared papers)H. R. Sullivan (6 shared papers)Robert H. Tukey (2 shared papers)
- Journals
- Molecular Pharmacology (5 papers)Archives of Biochemistry and Biophysics (4 papers)Life Sciences (3 papers)Toxicology and Applied Pharmacology (3 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United States
In The Last Decade
Ruth E. Billings
51 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 108
- Pharmacology 329
- Biochemistry 222
- Cancer Research 222
- Hepatology 76
- Health, Toxicology and Mutagenesis 126
Countries citing papers authored by Ruth E. Billings
This map shows the geographic impact of Ruth E. Billings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth E. Billings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth E. Billings more than expected).
Fields of papers citing papers by Ruth E. Billings
This network shows the impact of papers produced by Ruth E. Billings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth E. Billings. The network helps show where Ruth E. Billings may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth E. Billings, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 145 | |
| 2 | 1996 | 97 | |
| 3 | Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo(a)pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate. | 1981 | 84 |
| 4 | 1986 | 77 | |
| 5 | 1974 | 66 | |
| 6 | 1995 | 65 | |
| 7 | 1996 | 64 | |
| 8 | 1996 | 62 | |
| 9 | 1973 | 62 | |
| 10 | 1978 | 61 | |
| 11 | 1993 | 60 | |
| 12 | 1978 | 52 | |
| 13 | 1987 | 47 | |
| 14 | 1979 | 28 | |
| 15 | 1969 | 27 | |
| 16 | 1984 | 26 | |
| 17 | 1984 | 25 | |
| 18 | 1985 | 23 | |
| 19 | 1979 | 21 | |
| 20 | 1976 | 21 |
About Ruth E. Billings
Ruth E. Billings is a scholar working on Molecular Biology, Biochemistry, Pharmacology, Physiology and Pharmacology, having authored 51 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Eicosanoids and Hypertension Pharmacology (8 papers), Nitric Oxide and Endothelin Effects (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Carcinogens and Genotoxicity Assessment (5 papers), Analytical Chemistry and Chromatography (4 papers), Folate and B Vitamins Research (4 papers) and Chemical Reactions and Isotopes (4 papers). The work is most often cited by research in Pharmacology (329 citations), Biochemistry (222 citations), Cancer Research (222 citations), Hepatology (76 citations) and Health, Toxicology and Mutagenesis (126 citations). Ruth E. Billings has collaborated with scholars based in United States. Frequent co-authors include Gregory M. Adamson, Robert E. McMahon, Timothy J. Carlson, Thomas R. Tephly, Dawn L. Duval, David J. Sieg, H. R. Sullivan, Robert H. Tukey, David A. Blake and Franz Oesch. Their work appears in journals such as Molecular Pharmacology, Archives of Biochemistry and Biophysics, Life Sciences, Toxicology and Applied Pharmacology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.